The women’s health market has been historically characterized by numerous obstacles, ranging from insufficient research and funding to strict regulatory constraints on reproductive health. Recently, however, this sector has drawn significant attention, as evidenced by the increasing number of health startups focusing on women’s care. Notably, MedCity News has launched MedCity FemFwd, a podcast devoted to exploring challenges and advancements within women’s health.
On a monthly basis, MedCity News Reporter Marissa Plescia will engage with industry leaders to address key issues concerning women’s health, such as sexual health, fertility, pregnancy, menopause, and heart health. Reader suggestions for future episode topics can be submitted directly to the reporter via email.
In the inaugural episode of MedCity FemFwd, the focus lies on a significant innovation within the U.S healthcare system: Opill. This recent addition to the pharmaceutical market stands as the first daily oral contraceptive approved for over-the-counter use nation-wide. The episode features Michelle Long, senior policy analyst for the Women’s Health Policy program at KFF, as she delves into why this development holds considerable weight for women’s healthcare. Long also stimulates discussions on potential insurance coverage for the medication, a factor that could majorly impact accessibility and use of Opill.
This new podcast promises to enrich mainstream conversations around women’s health, shedding light on triumphs and hurdles alike in this ever-evolving field.